Control of vancomycin-resistant enterococci: One size fits all?

Clinical Infectious Diseases

Volumn 41, Issue 2, 2005, Pages 210-216

  Armeanu, Emilian ^a,d   Bonten, Marc J M ^b,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Julius Center for Health Sciences and Primary Care   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; DISEASE MODEL; DISEASE TRANSMISSION; ENTEROCOCCUS; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION CONTROL; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; DRUG UTILIZATION; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HANDWASHING; HEALTH PERSONNEL; HUMANS; INFECTION CONTROL; MODELS, BIOLOGICAL; VANCOMYCIN RESISTANCE;

EID: 22044455698     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/431206     Document Type: Review

References (27)

1. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319:157-61.
2. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 2002; 162:2223-8.
3. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 72:195-8.
4. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:565-7.
5. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol 1995; 16:105-13.
6. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-86.
7. Ostrowsky B, Steinberg JT, Farr B. Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients? Infect Control Hosp Epidemiol 2001; 22:116-9.
8. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998; 158:1127-32.
9. Bonten MJ, Austin DJ, Lipsitch M. Spread of resistant pathogens in hospitals. Clin Infect Dis 2001; 33:1739-46.
10. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci USA 1999; 96:6908-13.
11. D'Agata EMC, Horn MA, Webb GF. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci. J Infect Dis 2002; 185:766-73.
12. Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA. Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci USA 2004; 101:3709-14.
13. Hotchkiss JR, Strike DG, Simonson DA, Broccard AF, Crooke PS. An agent-based and spatially explicit model of pathogen dissemination in the intensive care unit. Crit Care Med 2005; 33:168-76.
14. Kirkland KB, Weinstein JM. Adverse effects of contact isolation. Lancet 1999;354:1177-8.
15. Pittet D, Boyce JM. Revolutionising hand hygiene in health-care settings: guidelines revisited. Lancet Infect Dis 2003; 3:269-70.
16. Cooper BS, Medley GF, Stone SP, et al. Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci USA. 2004; 101:10223-8.
17. Grundmann H, Satoshi H, Winter B, Tami A, Austin DJ. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 2002; 185:481-8.
18. Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG, Smith D. Projected benefits of active surveillance for vancomycin-resistant enterococci in ICU settings. Clin Infect Dis 2004; 38:1108-15.
19. Perencevich E, Lipsitch M, Harris AD, Weinstein MC, Fisman DN. Estimating the costs and benefits of active surveillance for vancomycin-resistant Enterococcus on ICU admission. Paper presented at: 11th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (Toronto, Ontario). 2001. Available at: http://www.shea -online.org. Accessed 18 January 2005.
20. Tacconelli E, Karchmer AW, Yokoe D, D'Agata EM. Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. Clin Infect Dis 2004; 39:964-70.
21. Rice LB, Lakticova V, Helfand MS, Hutton-Thomas R. In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci. J Infect Dis 2004; 190:2162-6.
22. Toro PL, Kubin CJ, Della-Latta P, Pancholi P, Hammer S. Linezolid- and vancomycin-resistant Enterococcus faecium bacteremia in a liver transplant patient treated with daptomycin after developing quinupristin-dalfopristin resistance [abstract K-870]. In: Program and abstracts of the 44th Interscience Conference on Antimicrobial and Chemotherapy (Washington DC). Washington, DC: American Society for Microbiology, 2004:76.
23. Herrero IA, Issa NC, Patel R. Nosocomial spread of linezolid-resistant vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346:867-9.
24. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004; 39:1182-89.
25. Duckro AN, Blom DW, Lyle EA, Weinstein RA, Hayden MK. Transfer of vancomycin-resistant enterococcus via Healthcare workers hands. Arch Intern Med 2005; 165:302-7.
26. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 14;348:1615-9.
27. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344:1427-33.